National Institute for Biological Standards and Control (NIBSC), 英国国家标准局,是WHO指定的国际标准品供应商,常规产品大量备货。

Product Number Description
00/410 MAPREC assay of poliovirus type 1 (Sabin).100% 480-A, 525-C DNA(1st International Reference Preparation)
00/416 Low Mutant Virus Reference for MAPREC assay of poliovirus type 1 (Sabin)(1st International Reference Preparation)
00/418 MAPREC assay of poliovirus type 1 (Sabin) (1st International Standard)
00/422 High Mutant Virus Reference for MAPREC assay of poliovirus type 1 (Sabin)(1st International Reference Preparation)
00/440 Influenza Antiserum A/Singapore/1/57 (H2)
00/442 Influenza anti B/Yamanashi/166/98 Serum
00/498 Diphtheria Antitoxin Human IgG
00/500 Botulinum Type A-E Antitoxin, Human Serum
00/542 Influenza anti- A/Chick/Scotland/59 (H5N1) Serum
00/546 Influenza Antigen B/Johannesburg/5/99
00/552 Influenza Antigen A/Duck/Singapore-Q/F119-3/97 (H5N3)
00/556 Influenza anti-B/Johannesburg/5/99/ Serum
00/572 Interferon Beta (Human, rDNA, Glycosylated) (3rd International standard)
00/574 Interferon Beta SER17 Mutein (Human, rDNA derived)
00/576 Interferon Beta (Human, Fibroblast-derived, Glycosylated)
007SP Human Anti-Pneumococcal capsule Reference Serum (1st International Standard)
01/412 Anti-Meningococcal Immunotype L3,7,9 Monoclonal Antibody
01/420 Interleukin-17 (Human rDNA derived)(WHO Reference Reagent)
01/426 Meningococcal group Y polysaccharide
01/450 Influenza anti B/Guangdong/120/2000 Serum
01/452 Influenza anti A/Panama/2007/99 (H3N2) HA serum
01/506 Botulinum type F antitoxin, equine
01/508 Botulinum type C antitoxin, equine
01/510 Botulinum Antitoxin Equine Type D
01/512 Botulinum type G antitoxin, equine
01/514 Anti-Meningococcal Serosubtype P1.7 Monoclonal Antibody
01/538 Anti-Meningococcal Serosubtype P1.16 mAb
01/546 Influenza Antigen B/Guangdong/120/2000
01/580 Thrombin, human(2nd International Standard)
01/600 Anti-Toxoplasma IgG, Human(International Standard)
01/602 Anti-Parvovirus B19, plasma, human(2nd International Standard)
01/612 Influenza Virus infectious B/Hawaii/10/01
01/614 Influenza Antigen A/New Caledonia/20/99
02/102 Influenza anti A/Panama/2007/99 Serum
02/144 Anti-Meningococcal Serosubtype P1.15 mAb
02/148 Anti-Meningococcal Serosubtype P1.4 mAb
02/178 Anti-Meningococcal Serosubtype P1.2 mAb
02/180 Anti-Meningococcal Serotype P2.2a mAb
02/182 Anti-Japanese Encephalitis Virus Plasma, Human
02/184 Anti-Japanese Encephalitis (Anti-JE) Virus Negative Control Plasma, Human
02/206 Factor XIII Plasma, Human (1st International Standard)
02/210 HIV (antibody), 1st International Reference Panel
02/226 IVIG negative control for use with IVIG + anti-D(WHO Reference Reagent)
02/228 IVIG + anti-D for use with negative control IVIG(WHO Reference Reagent)
02/230 Biotinylated Brad-5 (Bio-Brad-5)
02/232 Tetanus Toxoid (Non-Adsorbed)
02/286 Vascular Endothelial Growth Factor 165 (VEGF165)(recDNA, human sequence)(WHO Reference Reagent)
02/294 Influenza Antiserum A/chick/Italy/1347/99 (H7N1)
02/308 Anti-Meningococcal Serotype P3.4 mAb
02/310 Anti-Meningococcal Serotype P3.15 mAb
02/318 Botulinum Antitoxin Equine Type E
02/320 Anti-Meningococcal Serosubtype P1.3 mAb
02/336 Influenza Antigen A/New Caledonia/20/99
02/338 Influenza anti A/Panama/2007/99 Serum
02/342 Protein C Plasma, Human(2nd International Standard)
03/104 HTLV-1 (antibody) Monitor Sample
03/110 Influenza anti B/Shangdong/9/97 Serum
03/114 Anti-Meningococcal Serosubtype P1.1 mAb
03/124 Thrombopoietin ( Human rDNA derived)
03/142 Anti-Meningococcal Serosubtype P1.14 mAb
03/148 Keratinocyte growth factor (KGF, FGF-7)(24-163)(1st WHO Reference Reagent)
03/150 Keratinocyte Growth Factor (KGF,FGF-7)(1st WHO Reference Reagent)
03/152 Anti-HPA-1a (International Standard)
03/164 Anti-B minimum potency reference preparation(International Standard)
03/178 Vitamin B12, Serum Folate and holoTC (International standard)
03/182 Anti-Meningococcal Serotype P3.21 mAb
03/188 Anti-A minimum potency reference preparation(International Standard)
03/190 Anti-HPA-3a(minimum potency)(WHO Reference Reagent)
03/192 Thyroid-Stimulating Hormone, Recombinant, Human, for Bioassay (1st International standard)
03/200 Interleukin - 18 (Human rDNA derived)(WHO Reference Reagent)
03/210 Anti-Meningiococcal Serosubtype P1.6 mAb
03/212 Influenza anti A/Wyoming/03/03 Serum
03/220 Influenza Antigen A/Wyoming/03/03
03/224 Anti-Meningococcal Serosubtype P1.10 mAb
03/226 Anti-Meningococcal Serosubtype P1.5 mAb
03/228 Protein S, Plasma, Human(2nd International Standard)
03/236 Anti-Meningococcal Serosubtype P1.13 mAb
03/242 Influenza anti A/Puerto Rico/8/34 (H1N1) HA Serum
03/244 Influenza Antiserum A/chick/Germany/N/49
03/258 Influenza Antigen A/New Caledonia/20/99 (IVR-116)
03/262 Hepatitis B Surface Antigen subtype adw2, genotype A (International Reference Panel)
04/122 Anti-Meningococcal Serosubtype P1.12 mAb
04/160 Influenza Virus infectious NYMC X-147
04/166 TNF-related Apoptosis-Inducing Ligand (trail), Human, rDNA-derived(1st WHO Reference Reagent)
04/170 Influenza Virus infectious A/Wellington/1/2004
04/172 Influenza Virus infectious IVR-139
04/176 Plasmodium falciparum DNA for NAT Assays(1st International Standard)
04/198 Anti-Meningococcal Serotype P3.1 mAb
04/202 Influenza Antigen B/ Jiangsu/10/2003
04/224 Factor V Leiden, Human gDNA, 1st International Genetic Reference Panel 2004
04/228 Influenza anti B/ Neuraminidase Serum
04/242 Influenza anti B/Jiangsu/10/2003 HA Serum
04/246 Anti-Meningococcal Serogroup W-135 mAb
04/248 Anti-Meningococcal Serosubtype P1.19 mAb
04/252 Protein C Concentrate, Human(1st International Standard)
04/260 Influenza anti A/New Caledonia/20/99 HA Serum
04/262 Influenza anti A/New York/55/2004 HA Serum
04/264 Influenza Antigen A/New York/55/2004 (H3N2) (NYMC X-157)
05/102 Influenza Virus infectious NYMC BX-7
05/106 Anti-HPA-1a minimum potency reagent(2nd WHO Reference reagent)
05/112 Low Molecular Weight Heparin for Molecular Weight Calibration (2nd International Standard).
05/130 Prothrombin Mutation G20210A, Human gDNA(1st International Genetic Reference Panel 2005)
05/134 Anti-human papillomavirus type 16 serum (1st International Standard)
05/162 Alpha-1-Antitrypsin, plasma derived(1st International standard)
05/190 Anti Meningococcal Serosubtype P1.9 Monoclonal Antibody
05/192 Anti Meningococcal Serotype P2.2b Monoclonal Antibody
05/234 Influenza Antigen A/Hiroshima/52/2005 (H3N2) (IVR-142)
05/236 Influenza anti A/Wisconsin/67/2005 Serum
05/252 Influenza anti B Neuraminidase Serum
06/108 Influenza Virus infectious IVR-116
06/124 Monoclonal Antibody for Serotyping Bordetella pertussis Fimbrial Antigen 2 (1st International Standard)
06/128 Monoclonal Antibody for Serotyping Bordetella pertussis Fimbrial Antigen 3 (1st International Standard)
06/140 Pertussis Antiserum(human)1st IS-WHO international Standard.
06/142 Pertussis Antiserum (Human) 1st WHO Reference Reagent
06/164 Influenza Virus infectious 1 VR-142
06/166 Antithrombin Concentrate, Human (3rd International Standard)
06/170 Influenza Antigen A/New Caledonia/20/99
06/192 Influenza anti A/turkey/Turkey/1/05 (NIBRG-23) HA serum(sheepSH465 & SH466)
06/202 Human Papillomavirus (HPV) Type 16 DNA (1st International Standard)
06/206 Human Papillomavirus (HPV) Type 18 DNA (1st International Standard)
06/242 Influenza Virus Infectious NYMC X-161B (A/Wisconsin/67/2005 HGR)
688 SARS CoV-1 spike S1 protein
07/102 Influenza Antigen A/Solomon Islands/3/2006 (H1N1)(IVR-145)
07/104 Influenza anti A/Solomon Islands/3/2006 (H1N1) (IVR-145) HA Serum
07/112 Influenza Antigen A/turkey/Turkey/1/2005 (H5N1) NIBRG-23
07/132 Influenza Virus infectious B/Malaysia/2506/2004
07/144 Influenza Virus infectious IVR-145,
07/146 Influenza anti A/HongKong/1073/99 like (H9) HA Serum (sheep)
07/148 Influenza anti A/Vietnam/1194/04 (H5N1) HA Serum
07/150 Human Plasma Anti-Influenza H5N1 (1st International Standard)
07/164 Anti-hepatitis B surface antigen(Anti-HBs) immunoglobulin (2nd International Standard)
07/184 Influenza anti B/Malaysia/2506/2004-HA Serum
07/202 Recombinant soluble transferrin receptor (rsTfR)(1st WHO Reference Reagent)
07/216 Diphtheria Toxoid (Adsorbed) (4th International Standard)
07/222 RhD/SRY Plasma DNA sensitivity standard (1st WHO Reference Reagent)
07/228 Blood Coagulation Factor VIIa, Concentrate, Human, 2nd International Standard”
07/270 BCG Vaccine of Danish 1331 sub-strain (1st WHO Reference Reagent)
07/272 BCG Vaccine of Tokyo 172 sub-strain(1st WHO Reference Reagent)
07/274 BCG Vaccine of Russian BCG-I sub-strain(1st WHO Reference Reagent)
07/278 Influenza anti A/mallard/Netherlands/12/2000 (H7) HA serum (NIBRG-60) (sheep SH474 AND SH475)
07/286 Monitor sample for HBsAg 0.05IU/ml
07/288 Hepatitis B Surface Antigen (HBsAg) British Working Standard 0.2 IU/ml
07/290 Influenza Antigen A/Anhui/1/05 (H5N1) IBCDC-RG-6
07/296 Influenza Virus (A/Christchurch/1/2003, H1N1) for Nucleic Acid Amplification Techniques
07/298 Influenza Virus (A/Wyoming/3/2003, H3N2) for Nucleic Acid Amplification Techniques
07/300 Influenza Virus (B/Jiangsu/10/2003) for Nucleic Acid Amplification Techniques
07/304 Anti-D for assuring operator and test performance
07/306 Anti-A and anti-B in IVIG: Positive control for haemagglutination tests (WHO Reference Reagent)
07/316 Blood Coagulation Factor VIII and Von Willebrand Factor in Plasma (6th I.S.)
07/318 Meningococcal Group C Polysaccharide
07/328 Unfractionated Heparin (6th I.S.)
07/336 Influenza Antigen A/mallard/Netherlands/12/00(H7N3) NIBRG-60
07/338 Influenza antiserum A/Anhui/1/05 (H5)
07/348 Influenza Virus infectious NYMC X-171B
07/350 Blood Coagulation Factor VIII Concentrate (8th I.S.)
07/358 Influenza Virus infectious NIB-50
07/362 Influenza Virus infectious IVR-149
07/B498 QCRHBclgMQC1-IgM Anti-HBc Quality Control Serum: Sample1
08/100 Influenza Antigen A/Brisbane/59/2007 (IVR-148) (H1N1)
08/108 Influenza Virus Infectious NIBRG-91 (H9N2)
08/118 Parainfluenza Virus serotype 3 for Nucleic Acid Amplification Techniques
08/120 Human Respiratory syncytial virus A2 for Nucleic Acid Amplification Techniques
08/126 Influenza Anti N1 Neuraminidase Serum SH485
08/138 Influenza Virus Infectious B/Florida/4/2006
08/140 Influenza Antigen B/Florida/4/2006
08/142 Influenza antiserum A/Anhui/1/05 (H5)
08/148 HLA Class II Positive Control
08/154 Influenza Virus Infectious NIBRG-12 (H5N1)
08/156 Influenza Virus Infectious NIBRG-23 30060 VE3 (H5N1)
08/158 Fragile X Syndrome gDNA (1st International Genetic Reference Panel)
08/160 Haemophilia A, Intron-22 inversion, gDNA, (1st International Genetic Reference Panel)
08/174 Human Coxsackie B4 for Nucleic Acid Amplification Techniques
08/176 Parainfluenza Virus serotype 1 for Nucleic Acid Amplification Techniques
08/178 Parainfluenza Virus serotype 2 for Nucleic Acid Amplification Techniques
08/180 Parainfluenza virus serotype 4 for Nucleic Acid Amplification Techniques
08/184 Influenza Antigen B/Malaysia/2506/2004
08/202 Influenza anti A/chick/Hong Kong/G9/1997/(H9) HA serum (NIBRG-94)(H9N1)
08/204 Thyroid Stimulating Antibody (2nd I.S.)
08/208 Influenza Antigen A/HongKong/1073/99 (H9N2)
08/210 Influenza anti A/Cambodia/R0405050/2007 (H5) HA serum (NIBRG-86)
08/214 Meningococcal Serogroup C polysaccharide (1st International Standard)
08/216 Influenza Antigen A/Cambodia/RO405050/2007 (H5N1)
08/218 Tetanus Toxoid Adsorbed (4th International Standard)
08/228 Influenza Antigen A/chick/Hong Kong/G9/1997 (H9N2) NIBRG-91
08/230 Streptodornase (2nd International Standard)
08/246 Influenza anti A/Brisbane/10/2007- like HA serum
08/248 Influenza Virus Infectious NIBRG-107 VE2 30480
08/250 Influenza Virus Infectious NIBRG-63 VE2 30500 (H7N1)
08/252 Influenza Virus Infectious NIBRG-109 VE2 30490
08/256 C1- Inhibitor, Concentrate (1st International Standard)
08/258 Antithrombin, Plasma (3rd International Standard)
08/262 C1 Inhibitor (Plasma)(1st International Standard)
08/266 Sex Hormone Binding Globulin.(2nd International Standard)
08/268 Influenza Antigen A/mallard/England/727/2006 (H2N3)NIBRG-107
08/278 Influenza Antigen A/Brisbane/10/2007-like (Prepared from A/Uruguay/716/2007 (NYMC X-175C))
08/298 Influenza Virus Infectious B/Brisbane/33/2008 30720 E5
08/300 Influenza Virus Infectious IVR-148
08/304 Influenza virus infectious NYMC X-175C
08/318 Human Norovirus GI Working Reagent for Nucleic Acid Amplification Testing
08/320 Human Metapneumovirus Working Reagent for Nucleic Acid Amplification Testing
08/322 Human Parechovirus Working Reagent for Nucleic Acid Amplification Testing
08/356 Influenza antiserum A/Japan/305/57 (H2)
08/362 Influenza Antigen A/New York/107/2003 (H7N2)NIBRG-109
09/100 Influenza anti A/mallard/England/727/2006 (N3) NA serum (NIBRG-107) (Sheep SH503)
09/110 Parvovirus B19 DNA Nucleic Acid Amplification Technology(NAT) based assays Genotype Panel(1st International Standard)
09/130 Influenza Virus Infectious NIBRG-122
09/132 Human Coronavirus 229E Working Reagent for Nucleic Acid Amplification Testing
09/136 Granulocyte Colony Stimulating Factor (Human, rDNA Derived)(2nd International Standard)
09/138 Genetic Reference Panel, for the quantitation of BCR-ABL translocation by RQ-PCR (1st I.S.)
09/140 Prader Willi & Angelman Syndromes, Human gDNA,(1st International Genetic Reference Panel)
09/148 Influenza anti A/New York/107/2003 (H7) HA serum (Sheep SH504 and SH505)
09/162 Human Cytomegalovirus (HCMV) for Nucleic Acid Amplification Techniques (1st International Standard)
09/170 Anti-Meningococcal factor H binding protein variant 1 (JAR4) monoclonal antibody
09/172 Blood coagulation Factors II, VII, IX, X Plasma (4th International Standard 2010)
09/174 Influenza Antigen A/California/7/09 (H1N1)v (NYMCX-179A)(Cell Derived)
09/182 VWF Factor Concentrate (2nd International Standard)
09/184 Influenza Antigen A/Vietnam/1194/2004 (H5N1) NIBRG-14
09/186 Chagas (anti-Trypanosoma cruzi II) antibody in human plasma(1st International Standard)
09/188 Chagas (anti-Trypanosoma cruzi I) antibody in Human Plasma (1st International Standard)
09/196 Influenza Antigen A/California/7/09 (H1N1)v (NIBRG-121xp) (Egg Derived)
09/222 Human anti-Haemophilus influenzae b reference serum
09/234 Transforming Growth Factor-BETA 3 (Human, rDNA derived TGF-ß 3) (1st International Standard)
09/236 Influenza Virus Infectious IVR-153
09/242 Fibrinogen Concentrate (B)(2nd International Standard)
09/260 Epstein-Barr Virus for Nucleic Acid Amplification Techniques(1st International Standard)
09/264 Fibrinogen Plasma (D)(3rd International Standard)
09/268 Influenza Virus Infectious NIBRG-121xp
09/272 Placental growth factor Ala 21 - Arg 149, human, rDNA-derived (PlGF, PlGF-1)
09/274 Influenza Virus Infectious NYMC X-185
09/280 Influenza Virus Infectious NIB-64
09/284 Anti-Human Neutrophil Antibody 1a WHO Reference Reagent
09/296 Pro-Insulin, human (1st International Standard)
09/304 Influenza Virus Infectious IVR-155
09/306 Influenza Virus Infectious NIBRG-147 (H2N2)
09/308 Influenza Serology Antigen Reagent X-179A (H1N1pdm) for HI Assay
09/310 Influenza Antigen A/Wisconsin/15/09 (H3N2) (NYMCX-183)
10/104 Reteplase Reference Material
10/120 Influenza Anti A/Brisbane/59/2007 (IVR 148)(H1N1) HA serum
10/128 Diphtheria Polyclonal Antibody
10/130 Diphtheria Monoclonal Antibody
10/132 Tetanus Polyclonal Antibody
10/134 Tetanus Monoclonal Antibody
10/140 Anti-human papillomavirus[HPV] 18 serum (1st International Standard)
10/142 Anti-HLA Control
10/164 Oral Poliovaccine Sabin Type 1 reference strain [LS-c, 2ab strain].
10/168 Oral Poliovaccine Sabin Type 3 reference
10/176 Interleukin-29 (Interferon Lambda, Human, rDNA derived) WHO Reference Reagent
10/178 Endotoxin (3rd International Standard)
10/198 Anti-malaria (Plasmodium falciparum) human serum(1st WHO Reference Reagent)
10/202 Influenza antibody (Human) to A/California/7/2009 'like' (H1N1v) virus (2nd International Standard)
10/214 Influenza Anti N2 Neuraminidase Serum SH395 & SH396
10/218 Influenza Anti A/California/7/2009 (N1) NA Serum
10/226 Influenza Virus Infectious IVR-158
10/232 Blood Group Genotyping Reference Reagent RBC1 (OR1R2)(WHO Reference Reagent)
10/234 Blood Group Genotyping Reference Reagent RBC12 (ODpsi)(WHO Reference Reagent)
10/236 Blood Group Genotyping Reference Reagent RBC4 (AR1R1)(WHO Reference Reagent)
10/238 Blood Group Genotyping Reference Reagent RBC5 (Brr)(WHO Reference Reagent)
10/242 Toxoplasma gondii DNA Nucleic Acid Amplification Techniques(1st International Standard)
10/252 Factor VII Concentrate (2nd International Standard)
10/258 Influenza Antigen A/California/7/2009-like(NIB-74)
10/262 Diphtheria Antitoxin Human IgG(1st International Standard)
10/266 4th WHO International Standard for HBV DNA for NAT
10/272 BCG vaccine of Moreau-RJ sub-strain(1st WHO Reference Reagent)
10/286 Follicle Stimulating Hormone, Luteinizing Hormone human, urinary for bioassay(5th International Standard)
10/B596 QCRHSV1QC1-Anti-HSV1 Quality Control Serum: Sample1
100976 pCAGGS-SARS-CoV-2-Spike
100978 VeroE6/TMPRSS2
100980 SARS-CoV-2 infectious virus (BetaCoV/Australia/VIC01/2020
100982 SARS-CoV-2 Nucleoprotein
100985 pCAGGS_SARS-CoV-2_Spike D614G
100986 pCAGGS-SARS-CoV-2-Spike Bristol Deletion
100987 Inactivated SARS-CoV-2 (BetaCoV/Australia/VIC01/2020
100988 Nucleic acid extracts from inactivated SARS-CoV-2 (BetaCoV/Australia/VIC01/2020
100989 pCRII-SARS-CoV-2 (5'UTR-NSP2)
100991 pCRII-SARS-CoV-2 (NSP4-NSP8)
100992 pCRII-SARS-CoV-2 (NSP4-NSP8)
100994 pCRII-SARS-CoV-2 (NSP15-NSP16)
100996 pCRII-SARS-CoV-2 (ORF3a-ORF6)
100998 SARS-CoV-2 infectious virus (CVR-GLA 1)
100999 SARS-CoV-2 infectious virus(CVR-GLA 2)
101000 SARS-CoV-2 infectious virus(CVR-GLA 3)
101001 VeroE6-ACE2
101003 VeroE6-ACE2-TMPRSS2
101004 A549-ACE2-TMPRSS2
101005 A549-ACE2 Clone8
101006 A549-ACE-2 Clone 8-TMPRSS2
101007 SARS-CoV-2 Trimeric Spike 50ug (1mg/ml in PBS) Sterile #28.05.2020
101008 HEK293T-ACE2-TMPRSS2
101009 Anti-SARS-CoV-2 Nucleocaspid protein (CR3009)
101010 Anti-SARS-CoV-2 Nucleocapsid protein (CR3018)
101011 Anti-SARS-CoV-2 Nucleocapsid protein (CR3009 Human/Mouse HC)
101019 VOC-202012/01 (B.1.1.7 lineage) lot 26012021
101022 SARS-CoV-2 VOC202012/02 (B.1.351 lineage) passage 4
101023 pl.18SARS-CoV-2-Spike (B.1.1.7) 1ug (100ng/ul) lot #24032021
101024 pl. 18SARS-CoV-2-Spike (B.1.351) 1ug (100ng/ul) lot #24032021
101025 4% formaldehyde inactivated SARS CoV-2 BetaCoV/Australia/VIC01/2020 from VeroE6/TMPRSS2
101027 Acid/heat inactivated SARS-CoV-2 (B.1.1.7) lot 17022021
101029 SARS-CoV-2 Alpha (B.1.1.7) Purified RNA extracts lot 20052021
101030 SARS-CoV-2 VOC-202104/02 (B.1.617.2 lineage)
101031 SARS-CoV-2 VOC-21FEB02 (B.1.1.7 lineage + E484K)
101032 SARS-CoV-2 Kappa (B.1.617.1 lineage
101033 SARS-CoV-2 Delta (AY.1 sub-lineage)
101034 SARS-CoV-2 Mu (B.1.621 lineage)
101035 Acid/Heat Inactivated SARS-CoV-2 Beta (B.1.351 lineage)
101036 Acid/Heat Inactivated SARS-CoV-2 Delta (B.1.617.2 lineage
101038 0.01% Formaldehyde Inactivated SARS-CoV-2 Beta (B.1.351 lineage)
101039 0.01% Formaldehyde Inactivated SARS-CoV-2 Delta (B.1.617.2 lineage)
101042 SARS-CoV-2 Nucleocapsid protein (His tagged)
101043 SARS-CoV-2 Nucleocapsid protein 203/204:RG>KR (His tagged)
101044 SARS-CoV-2 Omicron (lineage B.1.1.529)
1050 IPV ELISA MAbs Type 1, 2 and 3 (Type 2; No: 1050)
11/108 Influenza Virus infectious NYMC X-187
11/126 Factors II and X Concentrate (4th International standard)
11/134 Influenza Antigen A/California/7/2009 (H1N1) Like (A/Brisbane/10/2010- cell derived)
11/170 Erythropoietin, recombinant, for Bioassay (3rd International Standard)
11/176 (3rd International Standard) Low Molecular Weight Heparin
11/184 High Molecular Weight Urokinase(2nd International Standard)
11/206 Influenza anti-A/Perth/16/2009 HA Serum
11/210 Anti-human CD4 FITC conjugated 0.5ml
11/212 Biosynthetic Human Insulin (2nd WHO international Standard)
11/214 Blood Group Genotyping Reference Reagents Panel (WHO Reference Reagent)
11/216 Chagas Antibody Reference Panel ( 1st International Standard)
11/222 Influenza Virus Infectious NIB-79
11/232 Influenza Virus Infectious B/Texas/6/2011
11/234 Immunoglobulin E(IgE) human serum (3rd International Standard)
11/242 Viral Multiplex Reference
11/244 Influenza Virus Infectiious NYMC BX-49
11/B608 QCRHIV1QC1-Anti-HIV1:Quality Control Serum: Sample1
12/100 Influenza Virus Infectious NYMC X-217
12/104 International Standard for IPV 12/104 (3rd International Standard)
12/106 Influenza Antigen B/Hubei-Wujiagang/158/2009 (NYMCBX-39)
12/110 Influenza Antigen B/Wisconsin/1/2010 (cell derived)
12/112 Influenza Antigen A/Victoria/210/2009 (H3N2) (NYMCX-187)
12/114 Influenza Antigen A/Victoria/361/2011 (H3N2) (IVR-165)
12/116 Influenza anti-A/Victoria/361/2011-like HA serum
12/118 Influenza anti-B/Wisconsin/1/2010-like HA serum
12/122 Influenza virus infectious A/turkey/Italy/3889/1999 (H7N1)
12/154 Tumour Necrosis Factor alpha (human rDNA derived)(3rd International Standard)
12/176 Methylated Human Serum Albumin (mHSA)
12/188 Pegylated Granulocyte Colony Stimulating Factor (Human, rDNA derived) (1st International Standard)
12/198 Influenza virus infectious B/Wisconsin/1/2010 34490 E5
12/202 Influenza virus infectious NYMC BX-39
12/204 Influenza Virus infectious IVR-165
12/208 Parvovirus B19 (3rd International Standard)
12/224 HIV-1 NAT subtypes (Main)(2nd International Reference Panel Preparation)
12/226 HBsAg (HBV genotype B4, HBsAg subtypes ayw1/adw2)(3rd International Standard)
12/244 Vi polysaccharide of C freundii WHO 1st International Standard
12/252 ADAMTS 13 Plasma (1st International Standard)
12/278 2nd Pneumococcal QC Serum Panel
12/282 Diphtheria Toxin 1Lf/ml
12/284 Anti-meningococcal serogroup Y monoclonal antibody
12/290 Influenza Virus Infectious B/Brisbane/36/2012
12/294 Influenza Virus Infectious NYMC BX-51C
12/300 Negative Control IVIG (for use with IVIG and Anti-D)
12/306 Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP)(2nd International Standard)
12/B611 Anti-VZV Quality control serum: Sample 1 QCRVZVIgMQC1
12/B612 QCRRUBIgMQC1-Anti-Rubella IgM Quality Control Serum: Sample 1
13/100 Activated Blood Coagulation Factor XI (FXIa), Human (1st International Standard)
13/106 Influenza Antigen B/Massachusetts/02/2012
13/108 Anti-Meningococcal serogroup B monoclonal antibody
13/112 Influenza Antigen A/Texas/50/2012 (NYMC X-223)
13/116 Influenza Antigen A/Texas/50/2012 (NYMC X-223A)
13/122 Erythropoietin Antibody Reference Panel Negative Control Antibody (1st WHO Reference Panel)
13/126 Influenza anti-B/Brisbane/60/2008-like HA serum
13/128 Influenza Virus Infectious NIBRG-269
13/132 Antibodies, Human, to Toxoplasma gondii (4th International Standard).
13/134 Influenza Antigen B/Massachusetts/02/2012 (Egg derived)
13/146 C-Peptide, Human (1st International Standard).
13/148 IVIG + anti-D for use with negative control IVIG
13/152 Influenza Antigen B/Massachusetts/02/2012 (Cell Derived)
13/162 Influenza Antigen A/Texas/50/2012 (NYMC X-223A) (Cell derived)
13/164 Influenza Antigen A/California/7/2009 (H1N1pdm)(NYMC X-179A)
13/166 Influenza anti-A/Anhui/1/2013 (N9) NA Serum
13/168 Human Measles Mvi/Moscow Rus/1988 Genotype A Virus for Nucleic Acid Amplification Techniques
13/172 Lupus Anticoagulant (1st International Reference Panel)
13/176 Influenza Virus Infectious NIBRG-88
13/178 Influenza Anti-A/Texas/50/2012-like HA Serum
13/182 Influenza Anti-B/Massachusetts/02/2012-like HA Serum
13/200 Influenza Virus Infectious NIB-74
13/202 Influenza Virus Infectious NIB-74xp
13/204 TNF Rec II- FC Fusion protein (1st International Standard)
13/206 Plasmin (4th International Standard)
13/212 Diphtheria Toxoid for use in Flocculation Test (3rd International Standard)
13/214 HIV-1 Circulating Recombinant Forms RNA (1st International Reference Panel)
13/216 Anti-meningococcal factor H binding protein variant 1 (JAR5) monoclonal
13/218 Polio Anti Sabin type 1 (inactivated) Serum
13/220 Polio Anti Sabin type 2 (inactivated) serum
13/222 Polio Anti Sabin type 3 (inactivated) serum
13/224 Influenza virus Infectious NIB-85. 36210 E5
13/228 Influenza Virus Infectious. A/Almaty/2958/2013. 35790 E4
13/234 Influenza antigen B/Brisbane/60/08
13/238 Anti-EV71 serum LOW (WHO Reference Reagent)
13/240 Tetanus Immunoglobulin, Human (2nd WHO International Standard)
13/242 FEIBA Concentrate 2nd NIBSC Working Reference Standard
13/246 Meningococcal serogroup A polysaccharide (1st WHO International Standard).
13/248 Influenza virus infectious NIBRG-267 (H7N9)
13/250 Influenza Virus Infectious NIBRG-268 (H7N9)
13/252 Influenza virus infectious NYMC X-223A
13/256 Influenza virus infectious. NYMC x-233
13/258 Influenza virus infectious NYMC X-233A
13/262 Meningococcal serogroup A polysaccharide
13/264 Influenza Virus Infectious NYMC X-223
13/B627 QCRMALQC1-Anti-Malaria Quality Control Serum: Sample1
13/B629 QCRHBeQC1 Anti-HBe Control Serum: sample1
13/B634 QCRHAVIgMQC2 IgM Anti-HAV Quality Control Serum: Sample2
13/B640 QCRHIV1QC5 - Anti-HIV-1 Quality Control Reagent Sample 5
13/B642 QCRHSV2QC1-Anti-HSV2 Quality Control Serum: Sample 1
13/B644 QCRHIV1QC3-Anti-HIV1:Quality Control Serum:Sample 3
14/100 Human Papillomavirus (HPV) 11 DNA (1st International Standard)
14/104 Human Papillomavirus (HPV) Type 45 DNA (1st International Standard)
14/106 Influenza virus infectious. NYMC BX-51B
14/114 JC Virus (JCV) DNA (1st International Standard)
14/116 Influenza virus infectious NYMC X-179A
14/118 Influenza virus infectious B/Massachusetts/2/2012
14/140 1st International Standard for Anti EV71 Serum Human
14/144 Influenza anti-N2 Neuraminidase serum (A/Victoria/361/2011)
14/146 Influenza Antigen B/Brisbane/60/2008 (NYMCBX-35)(Cell Derived)
14/148 Human Blood Factor IX Concentrate (5th International Standard).
14/156 Meningococcal group X polysaccharide (1st WHO International Standard)
14/160 High titre anti-A in IVIG working reference reagent
14/174 Botulinum Type A Antitoxin, Equine
14/198 HBV,HCV,HIV Multiplex
14/200 Influenza Antigen A/Puerto Rico/8/34 (HINI)
14/206 Influenza virus infectious NYMC X-247
14/210 Biological activities of Rituximab WHO 1st International Standard
14/212 BK Virus (BKV)(1st International Standard)
14/224 Influenza virus infectious. A/Switzerland/9715293/2013
14/226 Influenza Virus Infectious A/South Australia/55/2014
14/228 Influenza Virus Infectious A/Stockholm/6/2014
14/230 Influenza Virus Infectious. A/Norway/466/2014
14/232 Influenza Virus Infectious IVR-175
14/238 Recombinant Tissue factor
14/254 Influenza Antigen A/Switzerland/9715293/2013 (NIB88)
14/256 Human Papillomavirus (HPV) Type 6 DNA (1st International Standard)
14/258 Human Papillomavirus (HPV) Type 31 DNA (1st International Standard)
14/260 Human Papillomavirus (HPV) Type 33 DNA (1st International Standard)
14/262 Human Papillomavirus (HPV) Type 52 DNA (1st International Standard)
14/264 Human Papillomavirus (HPV) Type 58 DNA (1st International Standard)
14/274 Influenza Antigen B/Brisbane/9/2014 (Egg Derived)
14/300 High titre anti-A and anti-B in serum (WHO Reference Reagent).
14/306 Influenza Virus Infectious NYMC X-243 40180 E13
14/308 Influenza Virus Infectious IVR-178 40200 E7
14/314 Influenza Virus Infectious NIB-88
14/316 Factor IX activated (FIXa) 2nd WHO International Standard
14/318 Influenza Anti NIBRG-301 (H5) HA Serum (Sheep SH624 and SH625)
14/322 Influenza Virus Infectious NIB-91
14/B651 QCRTHBcQC2-Total Anti-HBc Quality Control Serum: Sample2
14/B653 QCRHIV2QC3- Anti HIV2: Quality Control Serum: Sample 3
14/B654 QCRRUBQC1-Anti-Rubella Quality Control Serum: Sample 1
14/B655 QCRVZVQC1-Anti VZV: Quality Control Serum: Sample 1
15/100 Influenza Antigen B/Utah/9/2014 (Cell Derived)
15/102 Activated Blood Coagulation Factor X (FXa), Human
15/104 Influenza Antigen A/South Australia/55/2014 Cell derived
15/106 Ancrod
15/126 Bordetella pertussis toxin (20µg). (2nd International Standard)
15/130 Clinical Virology Multiplex I: Immunodeficiency panel working reagent for Nucleic Acid Amplification Tests (NAT)
15/134 Influenza Anti-A Switzerland/9715293/2013-Like HA serum
15/136 EBOV RNA NP-VP35-GP in-run control
15/138 EBOV RNA VP40-L in-run control
15/140 Batroxobin
15/148 Influenza Virus Infectious NIB-92
15/154 Influenza Virus Infectious NIB-93
15/158 Influenza Virus Infectious NYMC X-263
15/160 Influenza Virus Infectious NIBRG-306
15/174 Lupus (oligo-specific) anti-dsDNA antibodies WHO Reference Reagent
15/180 Blood Coagulation Factor XI, 2016 Plasma Human (2nd International Standard). Blood Coagulation Factor XII, 2017 Plasma, Human (1st International Standard)
15/182 7th British Working Standard for Blood Coagulation Factors II, IX, X Concentrate
15/184 Influenza Virus Infectious NYMC X-263B
15/188 Influenza Virus Infectious NYMC X-263A
15/194 Influenza Virus Infectious NYMC X-257A
15/196 Influenza Virus Infectious NYMC X-261
15/212 Influenza Virus Infectious NYMC BX-53C
15/220 Anti-EBOV plasma, human (WHO Reference Reagent)
15/222 EBOV RNA NP-VP35-GP (WHO Reference Reagent)
15/224 EBOV RNA VP40-L (WHO Reference Reagent)
15/234 Influenza Virus Infectious B/Texas/2/2013 41340 E7
15/238 Influenza Antigen A/New Caledonia/71/2014 (NYMCX-257A)(Egg derived antigen)
15/240 Erythropoietin Antibody Reference Panel A (1st WHO Reference Panel)
15/242 Erythropoietin Antibody Reference Panel B (1st WHO Reference Panel)
15/248 Influenza Anti A/Anhui/1/2013 (H7) HA Serum (Sheep SH644 & SH645)
15/250 Influenza Virus Infectious NYMC BX-31
15/252 Influenza Virus Infectious A/California/7/2009
15/262 1st International Standard for Ebola virus (EBOV) antibodies Sierra Leone Convalescent Plasma Pool
15/266 HHV-6 Virus 1st WHO International Standard
15/270 CD4 WHO Reference Reagent
15/272 ICS Positive Control-Lymphocytes
15/276 Hepatitis A Virus VL For Nucleic Acid Amplification Techniques (3rd International Standard)
15/294 Influenza virus infectious NYMC BX-59B
15/296 Sabin monovalent Polio vaccine type 2 (1st International Standard)
15/298 Influenza Virus Infectious B/Brisbane/46/2015
15/300 Influenza Virus Infectious NYMC BX-35 41950 E11
15/304 Parathyroid hormone 1-34, recombinant, human, 2nd WHO International Standard
15/B658 QCRLYMEQC1 - Anti-Lyme QC1
15/B664 QCRMUMPSQC1 - Anti-Mumps Quality Control Reagent Sample 1
15/B667 QCRMEASQC1 Anti-Measles QC1
15/B671 QCRHIV1P24QC1-HIV1 p24 Antigen: Quality Control Serum: Sample1
15/B678 QCRPARVB19QC1 Anti-Parvovirus B19QC1
15/B680 QCRHBsQC1- Anti HBs Quality Control Serum: Sample 1
16/104 Norovirus GII Working reagent for Nucleic Acid Amplification Techniques
16/106 Influenza antigen A/California/7/09 (H1N1) (NYMC-X181)
16/108 Influenza Virus Infectious A/PR/8/34
16/110 Zika Virus Working Reagent for Nucleic Acid Amplification Testing (NAT)
16/114 Influenza anti - A/California/7/09 HA serum
16/118 Influenza Antigen B/Brisbane/60/2008 (NYMC BX-35) (Egg Derived)
16/120 WHO 1st International Reference Panel for Genomic JAK2 V617F
16/126 Native Vi polysaccharide (S. Typhi) (1st International Standard)
16/138 Anti-Typhoid capsular Vi polysaccharide Ig (Human) 1st WHO International Standard
16/152 Meningococcal Serogroup W Polysaccharide
16/164 Sabin bivalnet Polio vaccines types 1 and 3 (1st International Standard)
16/170 Infliximab (1st International Standard)
16/182 Influenza Anti-A/Hong Kong/4801/2014-like HA Serum
16/190 Mullerian Inhibiting Substance/Anti-Mullerian Hormone, human, recombinant (WHO reference Reagent)
16/192 Influenza Anti - B/Brisbane/60/2008-HA serum
16/194 HIV-1 RNA (4th International Standard)
16/196 Sabin monovalent Polio vaccine type 1(1st International Standard)
16/200 Influenza Virus Infectious NIB-58
16/202 OPV reference mOPV 3
16/204 7th WHO International Standard for Rabies Vaccine
16/206 Meningococcal serogroup Y Polysaccharide
16/208 Influenza Virus Infectious NIB-97 42090 E7
16/210 HIV-1 P24 Antigen (1st international reference panel)
16/236 HIV-2 p26 Antigen (VLP)-HIV-2 A7312 (1st WHO Reference Reagent)
16/238 Influenza Antigen A/Anhui/1/2013 (NIBRG-268) (H7N9)
16/242 Influenza Virus Infectious NIB-98 42110 E7
16/250 1st International Reference Panel for genomic KRAS codons 12 and 13 mutations
16/268 Influenza Virus Infectious X-273
16/270 Influenza Virus Infectious IVR-180 42400 E3/D7/E1
16/274 Influenza Virus Infectious X-275A 42010 E13
16/278 Anti-D Immunglobulin control preparation
16/282 Influenza Virus Infectious X-285 42430 ExE1
16/284 Antiserum to Respiratory Syncytial Virus WHO 1st International Standard
16/286 Influenza Antigen A/Hong Kong/4801/2014 (NYMC X-263B)
16/288 Influenza Virus Infectious X-283A 42420 ExE1
16/290 Influenza Virus Infectious X-285A 42440 ExE1
16/292 Influenza Antigen A/Singapore/GP1908/2015 (IVR-180)
16/296 Human Immunodeficiency Virus type 2 RNA (HIV-2) for Nucleic Acid Amplification Techniques (2nd International Standard)
16/302 Tetanus Toxoid for use in Flocculation Test (3rd International Standard)
16/320 Zika Antibody Working reagent
16/324 Human Adenovirus DNA for nucleic acid amplification techniques (1st WHO international Standard).
16/332 Anti-D Immunoglobulin (Replacement IS)
16/344 WHO Anti-EBOV Convalescent Plasma (International Reference Panel)
16/352 Anti-Asian Lineage Zika Virus Antibody (human) (1st international standard)
16/358 Streptokinase (4th WHO International Standard)
16/360 Influenza Virus Infectious NIB-96 41920 E7
16/362 Influenza Virus Infectious NYMC X-291 42530 E8
16/364 3rd International Standard for Prekallikrein Activator
16/366 Influenza Virus Infectious NYMC X-291A 42540 E8
16/368 HSV-1
16/374 Blood Coagulation Factor V, Plasma, Human. (WHO 2nd International Standard)
16/376 Plasmodium falciparum antigens (1st International Standard)
16/B687 QCRHIV1RTDQC1- Anti-HIV1 Quality Control Serum: Sample 1 for Rapid Test Devices
16/B695 QCRTOXOIgMQC1 IgM Anti-Toxoplasma gondii QC1
16/B704 QCRTHBcQC1-Total Anti-HBc Quality Control Serum: Sample 1
17/100 Prostate Specific Antigen (human)(total: PSA-ACT + free PSA)
17/102 Prostate Specific Antigen (human) (Free), (2nd WHO International Standard)
17/106 Influenza Anti-A/Michigan/45/2015-like HA Serum
17/122 HSV-2
17/124 Influenza Virus Infectious NYMC BX-63 42790 E10/E1
17/126 Influenza Virus Infectious NYMC BX-63A 42780 E10/E1
17/132 Influenza Anti NIBRG-306 (H5) HA Serum (sheep SH672 and SH637)
17/136 Influenza Virus Infectious NIBRG-375 (H7N9)
17/142 Influenza Antigen A/Duck Vietnam/NCVD-1584/2012 (NIBRG-301) (H5N1)
17/154 Influenza Antigen A/Michigan/45/2015 (NYMC X-275)
17/156 Influenza Virus Infectious CNIC-1701 42910 E9
17/160 Sabin Inactivated Polio Vaccine (sIPV) (WHO 1st international Standard)
17/162 Influenza Virus Infectious NYMC X-299 42920 E10
17/164 Influenza Virus Infectious B/Maryland/15/2016 42800 E5
17/182 Influenza Antigen A/Michigan/45/2015 (NYMC X-275)
17/184 Influenza Virus Infectious NIB-103 42610 E7
17/190 Influenza Virus Infectious NYMC X-297 42940 E11
17/194 Influenza Virus Infectious NIB-104
17/204 1st International Standard for Darbepoetin
17/206 14th British Standard for Coagulation Factor VIII Concentrate, Human.
17/210 Influenza Virus Infectious IVR-186 43310 E8
17/212 Anti-HLA Negative Control for FCXM and bead- based assays
17/232 Tumor Necrosis Factor alpha (human rDNA derived)
17/236 Adalimumab (1st WHO International Standard)
17/238 Anti-HLA Positive Control for FCXM and bead-based assays
17/240 5% Immunoglobulin (Negative Control)
17/246 Influenza Antigen A/Singapore/INFIMH-16-0019/2016 (NIB-104)
17/252 Influenza Virus Infectious NYMC BX-69 43220 E13
17/256 Influenza Virus Infectious NYMC BX-69A
17/258 Influenza Virus Infectious B/Alabama/2/2017
17/264 Influenza Virus Infectious A/Michigan/45/2015 43470 E5
17/B710 QCRTOXOQC1 - Anti-Toxoplasma gondii Quality Control Reagent Sample 1
17/B713 QCRSYPHQC2-Anti-Syphilis Quality Control Serum: sample 2
17/B717 QCRHBsGQC1-HBsAg Quality Control Serum: Sample1
17/B718 QCRHBsGQC2-HBsAg Quality Control Serum: Sample2
17/B723 QCRHEVQC1 - Anti-Hepatitis E Quality Control Sample 1
17/B725 QCRTHAVQC1-Total Anti-HAV Quality Control Serum: Sample1
17/B728 QCRHEVIgMQC1 - IgM Anti-Hepatitis E Quality Control Sample 1
18/100 Influenza Antigen B/Maryland/15/2016
18/104 Influenza Antigen B/Maryland/15/2016 (NYMC BX-69A)
18/108 Influenza anti-A/Singapore/INFIMH-16-0019/2016- like HA serum
18/110 Influenza Antigen A/Singapore/INFIMH-16-0019/2016 (IVR-186)
18/112 Influenza anti-A/Guangdong-17SF003/2016 (H7) (NIBRG-375) HA Serum
18/116 WHO International Standard Enterovirus 71 (EV71) Inactivated vaccine (Geno Group C4)
18/118 1st International Standard for HCT 15 Cancer Genome
18/120 WHO Reference Reagent Enterovirus 71 (EV71) Inactivated Vaccine (Geno Group C4)
18/130 1st International Standard for MOLT-4 Cancer Genome
18/134 Influenza Virus Infectious NIBRG-301 (H5N1)
18/136 Influenza Virus Infectious NIBRG-14 (H5N1)
18/138 Influenza Virus Infectious NYMC X-307A
18/140 Influenza Virus Infectious NYMC X-307
18/144 WHO 1st Reference Reagent for Lentiviral Vector Integration Site Analysis
18/146 Pertussis antiserum (human) panel
18/154 Bordetella pertussis, pertactin, PRN
18/156 WHO Reference Reagent Enterovirus 71 (EV71) Inactivated Vaccine (Geno Group B4)
18/160 Influenza Virus Infectious NYMC X-311
18/164 1st International Standard for ATDB102 Genome
18/166 Influenza Virus Infectious NIB-112 43990 E6
18/168 Influenza Virus Infectious A/Switzerland/8060/2017
18/170 Influenza anti-B/Colorado/06/2017-like HA serum
18/174 Influenza Virus Infectious A/Brisbane/1/2018
18/184 Hepatitis C virus RNA for nucleic acid amplification techniques (6th WHO International Standard)
18/188 Influenza Antigen A / Switzerland / 8060 / 2017 (NIB-112)
18/190 Influenza Antigen A / Brisbane/ 01/2018 (NYMC X-311)
18/192 Influenza Anti-A/Switzerland/8060/2017-like (H3N2) HA Serum
18/194 Influenza Virus Infectious NYMC X-275 (Influenza Reagent)
18/196 Influenza Antigen A/Guangdong/17SF003/2016. NIBRG-375 (H7N9)
18/206 West Nile Virus - International Standard
18/208 WHO Reference Reagent for West Nile Virus lineage 2 RNA for NAT-based assays
18/210 Bevacizumab (1st WHO International Standard)
18/220 Anti-HPA 15b minimum potency reagent (WHO Reference Reagent)
18/226 Influenza Virus Infectious IVR-190 44250 E12
18/230 Influenza Virus Infectious B/Colorado/06/2017 43460 E7
18/234 Influenza Virus Infectious NIB116-B 44230 E5
18/236 Influenza Virus Infectious A/Brisbane/02/2018
18/238 Influenza Antigen A/Brisbane/02/2018 (IVR-190) (H1N1)
18/240 Influenza Virus Infectious NYMC X-327 44280 E17
18/242 Influenza Virus Infectious A/Kansas/14/2017 43880 E8
18/244 Human Chorionic Gonadotropin (hCG) (6th International Standard)
18/B731 Anti CMV QC1 QCRCMVQC1
18/B732 QCRNEGQC1-Negative Quality Control Serum: Sample1
18/B742 QCRLYMEIgMQC1 IgM Anti-Lyme QC1
19/102 Influenza anti-A/Brisbane/02/2018-like (H1N1) HA Serum (Sheep 698, 699, 700, 701)
19/104 Influenza antigen A/Kansas/14/2017 (NYMC X-327) (H3N2)
19/106 Influenza Virus Infectious IVR-195 44300 E9
19/108 Trastuzumab (1st WHO international Standard)
19/112 Influenza Virus Infectious NIB-110
19/116 1st WHO Plasmodium Vivax Antigen (LDH)
19/118 Ferritin (Human, Recombinant)
19/120 Influenza Virus Infectious X-327 A 44310 E18
19/146 Influenza Virus Infectious CNIC-1903
19/148 Influenza Virus Infectious CNIC-1902 44320 E10
19/152 Influenza anti-A/Kansas/14/2017 - Like (H3N2) HA Serum
19/154 Influenza Antigen A/Kansas/ 12/2017 (IVR-195) (H3N2)
19/156 Panel of recombinant antibody controls for Cytokine Release Assays
19/160 Influenza Virus Infectious A/California/7/09 44430 E6
19/164 VZV Nucleic acid amplification techniques (1st WHO International Standard)
19/166 Insulin-like Growth Factor I, for Immunoassay (2nd WHO international Standard)
19/172 Influenza Virus Infectious BVR-11
19/174 Influenza Virus Infectious IVR-197 (H3N2) 44850 E14
19/176 Influenza Virus Infectious B/Victoria/705/2018
19/178 1st WHO International Standard for Anti-MERS-CoV Immunoglobulin G (Human)
19/180 Non WHO Reference material Working reagent for Anti-MERS-CoV Antibody
19/188 3rd International Standard Thrombin
19/192 Influenza Virus Infectious IVR-202 (H3N2) 44880 E10
19/194 Influenza Virus Infectious B/Brisbane/35/2018
19/198 1st WHO Reference Reagent for anti-malaria (Plasmodium Vivax) human plasma
19/204 Influenza Antigen A/Newcastle/82/2018 (H3N2) (cell derived)
19/206 Influenza Virus Infectious X-181 45030 E8
19/208 Influenza Antigen B/Victoria/705/2018 (BVR-11) (B Victoria Lineage)
19/210 Influenza Antigen B/Darwin/7/2019 (B Victoria Lineage) (Cell Derived)
19/212 Influenza Antigen A/South Australia/34/2019 (IVR-197) (H3N2)
19/216 Influenza Anti-A/South Australia/34/2019-Like (H3N2) HA Serum (Sheep 712, 713, 714, 715, 716)
19/224 Collection of WHO International Standards for Human Papillomavirus (HPV) DNA genotypes HPV16, HPV18, HPV6, HPV11
19/226 Collection of WHO International Standards for Human Papillomavirus (HPV) DNA genotypes HPV31, HPV33, HPV45, HPV52, HPV58
19/228 Influenza Virus Infectious A/South Australia/34/2019
19/230 Influenza Virus Infectious A/Christchurch/516/2019 H3N2 45010 E4
19/236 Diphtheria Antitoxin Equine (DI) (WHO International Standard)
19/238 Influenza Antigen B/Washington/02/2019 9B Victoria Lineage)
19/240 British Working Standard for Anti-HCV
19/242 British Working Standard for Anti HCV 1 in 8 Dilution
19/256 Influenza Virus Infectious BX-85C 45230 E13
19/258 Influenza Virus Infectious CNIC-1906 44910 E3+3/E9/E1
19/260 Anti-thyroid peroxidase antibodies (1st WHO International Standard)
19/276 Influenza Virus Infectious NIB-121 (H3N2) 45180 E7/E1/E5
19/304 Research reagent for SARS-CoV-2 RNA
19/306 Influenza Antigen A/Victoria/2454/2019 (IVR-207) (H1N1)
19/308 Influenza Antigen B/Singapore/INFTT-16-0610/2016 (B Yamagata lineage) (cell derived)
19/312 Influenza Antigen A/Guangdong-Maonan/SWL1536/2019 (CNIC-1909) (H1N1)
19/314 Influenza Anti-A/ Guangdong-Maonan/SWL 1536/2019-like (H1N1) HA Serum (Sheep 723, 724, 725, 726, 727, 728)
19/316 Influenza anti-A/hongKong/2671/2019-like (H3N2) HA Serum (Sheep 729, 730, 731, 732, 733, 734)
19/318 Influenza anti-B/Washington/02/2019-like (B Victoria lineage) HA Serum (Sheep 737, 738, 739, 740, 741, 742)
19/320 Influenza anti-N2 Neuraminidase Serum (A/South Australia/34/2019) (Sheep 735, 736)
19/322 Influenza anti-B/Phuket/3073/2013-like (B Yamagata Lineage) HA serum (Sheep 743, 744, 745, 746, 747, 748)
19/B747 QCRHIV2QC4 - Anti HIV2 Quality Control Serum Sample 4
19/B754 Anti-Rubella QC2
20/102 Influenza Virus Infectious IVR-207 (H1N1) 45370 E4/E6/E1
20/104 Influenza Virus Infectious IVR-208 (H3N2) 45330 E7/E10/E1
20/106 Influenza Virus Infectious A/Victoria/2454/2019 (H1N1) 45360 E4/E1
20/108 Influenza Antigen A/HongKong/2671/2019 (NIB-121)(H3N2)
20/110 SARS-CoV-2 (NAT)
20/112 IVIG + Anti-D (13/148)x2 Negative Control IVIG (12/300) x2
20/132 Influenza Antigen A/HongKong/2671/2019 (IVR-208) (H3N2)
20/134 Influenza Virus Infectious BX-57 45430 E4/E10/E1
20/138 Working Reagent for SARS-CoV-2 RNA
20/146 First WHO International Standard for SARS-CoV-2 RNA
20/152 First WHO International Standard for Mycobacterium tuberculosis (H37Rv) DNA for NAT-based assays
20/162 NIBSC Anti-SARS-CoV-2 Antibody Diagnostic Calibrant
20/164 Influenza Virus Infectious BX-87C (B/VIC) 45460 E3/E10/E1
20/170 NHS winter Multiplex Working Reagent for Nucleic acid amplification testing (NAT)
20/180 Influenza A (H1N1) Panel
20/182 Influenza A (H3N2) Panel
20/184 Influenza B Panel
20/186 RSV A Panel
20/188 RSV B Panel
20/190 SARS-CoV-2 Panel
20/202 Anti-Lassa Virus Antibodies (1st International Standard)
20/214 Influenza Virus Infectious IVR-216 (H1N1) 45630 E4/D6/E1
20/218 Follicle Stimulating Hormone (3rd International Standard)
20/220 Influenza Virus Infectious IVR-217 (H1N1) 45640 E4/D6/E1
20/232 Influenza Antigen A/Victoria/2570/2019 (IVR-215) (H1N1)
20/234 Influenza Anti-A/Victoria/2570/2019-like (H1N1) HA Serum (Sheep 749, 750, 751, 752, 753, 754)
20/236 Influenza Virus Infectious X-349 (H1N1) E3/E9/E1 45720
20/238 Influenza Virus Infectious X-349A (H1N1) E3/E11/E1 45730
20/264 Influenza Virus Infectious X-341 + 1P (H3N2)
20/266 Nucleic Acid Amplification Technique (NAT) Panel for SARS-CoV-2
20/294 Influenza Virus Infectious X-347 (H3N2)
20/296 Influenza Virus Infectious X-347A (H3N2)
20/310 Influenza Virus Infectious A/Cambodia/E0826360/2020 (H3N2)
20/318 Influenza Virus Infectious IVR-221 (H3N2)
20/322 Influenza Virus Infectious A/Singapore/INFIMH-16-0019/2016 (H3N2)
20/B758 QCRHIV1p24QC2-HIV1 p24 Antigen: Quality Control Serum: Sample2
20/B762 Anti-HIV Quality Control Serum sample 2
20/B767 QCRSYPHQC1-Anti-Syphilis Quality Control Serum: Sample 1
20/B770 Anti-SARS-CoV-2 Verification Panel for Serology Assays
20/B774 QCRPARVB19IgMQC1 - IgM Anti-Parvovirus B19 Quality Control Reagent 1
21/100 Influenza Antigen A/Cambodia/e0826360/2020 (IVR-224) (H3N2)
21/116 Influenza Antigen A/Tasmania/503/2020 (IVR-221) (H3N2)
21/118 Influenza anti-A/Cambodia/e0826360/ 2020-Like (H3N2) HA Serum
21/122 Influenza Virus Infectious X-357A (H3N2)
21/124 Influenza Virus Infectious B/HongKong/574/2019 (B-Victoria lineage)
21/126 NIBSC Reference Reagent for gut microbiome analysis by NGS (DNA-Gut-Mix)
21/128 NIBSC Reference Reagent for Gut microbiome analysis by NGS (DNA-GUT-HiLo)
21/130 Influenza Virus Infectious SAN-004A (H3N2)
21/132 Influenza Virus Infectious B/Phuket/3073/2013 (B-Yamagata lineage)
21/136 Influenza Antigen B/Phuket/3073/2013 (B Yamagata lineage)
21/148 Influenza Virus Infectious X-359 (H3N2)
21/150 Influenza Virus Infectious X-359A (H3N2)
21/156 Influenza Virus Infectious BX-93A (B-Victoria Lineage)
21/158 Influenza Virus Infectious BX-93B (B-Victoria Lineage)
21/160 Influenza Virus Infectious X-353 (H3N2)
21/164 Influenza Virus Infectious X-355B (H3N2)
21/166 Influenza Virus Infectious X-355A-CL (H3N2)
21/180 Meningococcal Capsular Group W polysaccharide
21/186 Influenza Virus Infectious A/Tasmania/503/2020 (H3N2)
21/190 Influenza Virus Infectious X-361A (H3N2)
21/192 Influenza Virus Infectious BX-97A (B-Victoria Lineage)
21/194 Influenza Virus Infectious A/Hong Kong/2671/2019
21/196 Influenza Virus Infectious IVR-224 (H3N2)
21/204 Influenza Virus Infectious IVR-227 (H3N2)
21/212 Influenza Virus Infectious A/Darwin/6/2021 (H3N2)
21/214 Influenza Virus Infectious A/Darwin/9/2021 (H3N2)
21/216 Influenza Virus Infectious BVR-25 (B-Victoria Lineage)
21/218 Influenza Virus Infectious BVR-26 (B/Victoria Lineage)
21/224 Influenza Virus Infectious B/Austria/1359417/2021 (B/Victoria Lineage)
21/226 Influenza Virus Infectious NIB-127 (H3N2)
21/228 Influenza Virus Infectious NIB-126 (H3N2)
21/234 Working reagent for anti-SARS-CoV-2 immunoglobulin
21/238 Influenza Virus Infectious A/Guangdong-Maonan/SWL/1536/2019 (H1N1)
21/240 Influenza Virus Infectious CNIC-1909 (H1N1)
21/242 Influenza Virus Infectious B/Singapore/WUH4618/2021 (B-Victoria Lineage)
21/244 Influenza Virus Infectious B/Michigan/1/2021 (B/Victoria Lineage)
21/246 Influenza Virus Infectious IVR-228 (H3N2)
21/248 Influenza Virus Infectious BVR-27 (B-Victoria Lineage) 46580
21/252 Influenza Virus Infectious IVR-215 (H1N1)
21/268 Anti-pneumococcal serotype 1 monoclonal antibody
21/270 Anti-pneumococcal serotype 3 monoclonal antibody
21/272 Anti-pneumococcal serotype 5 monoclonal antibody
21/274 Anti-pneumococcal serotype 6A / 6C monoclonal antibody
21/276 Anti-pneumococcal serotype 7F monoclonal antibody
21/278 Anti-pneumococcal serotype 8 monoclonal antibody
21/280 Anti-pneumococcal serotype 9N monoclonal antibody
21/282 Anti-pneumococcal serotype 9V monoclonal antibody
21/284 Anti-pneumococcal serotype 10A monoclonal antibody
21/286 Anti-pneumococcal serotype 12F monoclonal antibody
21/288 Anti-pneumococcal serotype 14 monoclonal antibody
21/290 Anti-pneumococcal serotype 18C monoclonal antibody
21/292 Anti-pneumococcal serotype 19A monoclonal antibody
21/294 Anti-pneumococcal serotype 22F monoclonal antibody
21/298 Influenza Virus Infectious A/Michigan/173/2020 (H3N2)
21/306 Influenza Virus Infectious SAN-010 (H3N2)
21/314 Influenza Antigen A/Darwin/6/2021 (IVR-227) (H3N2)
21/316 Influenza Antigen B/Austria/1359417/2021 (BVR-26) (B Victoria Lineage)
21/318 Influenza Antigen A/Darwin/9/2021 (IVR-228) (H3N2)
21/320 Influenza Antigen A/Darwin/9/2021 (SAN-010) (H3N2)
21/322 Influenza Anti-B Neuraminidase Serum (B/Phuket/3073/2013)
21/324 Influenza Anti-A/Darwin/9/2021-Like (H3N2) HA Serum
21/326 Influenza Anti-B/Austria/1359417/2021 Like (B Victoria Lineage) HA Serum
21/330 Influenza Antigen B/Michigan/01/2021
21/332 1st International Reference Panel for anti-Lassa fever virus antibodies
21/336 Influenza Virus Infectious B/Washington/02/2019 (B-Victoria lineage)
21/346 Influenza Virus Infectious A/Victoria/2570/2019 (H1N1)
21/348 Influenza Virus Infectious B/Utah/9/2014 (B-Yamagata lineage)
21/350 Influenza Virus Infectious BX-59A (B-Yamagata lineage)
21/352 Influenza Virus Infectious B/Brisbane/9/2014 (B-Yamagata)
21/366 Influenza Virus Infectious SAN-011 (H1N1)
21/B777 Ferritin Quality Control Sample
234 IPV ELISA MAbs Type 1, 2 and 3 (Type 1; No: 234)
2BADS Anti-Brucella Abortus Serum, Bovine (International Standard)
2CPBETAAT Clostridium Perfringens Beta Antitoxin (2nd International Standard)
2CPEPAT Clostridium Perfringens Epsilon Antitoxin (2nd International Standard)
4024 Antisera to SARS CoV-1 S1 Protein (Rabbit)
520 IPV ELISA MAbs Type 1, 2 and 3 (Type 3; No: 520)
59/015 Gas Gangrene (Cl. Perfringens(Cl. Welchii) Type A), Equine
59/016 Corticotrophin (ACTH), Porcine (3rd International Standard)
59/021 Botulinum Antitoxin Equine Type A
60/001 Botulinum Antitoxin Equine Type B
60/013 Tetanus Antitoxin, Equine, for Bioassay
62/014 Lysine Vasopressin, Porcine
63/005 Gas Gangrene Antitoxin (Cl. Histolyticum), Equine
64/002 Rheumatoid Arthritis Serum
64/014 Gas Gangrene Antitoxin (Cl. Septicum), Equine
64/024 Gas Gangrene Antitoxin (Cl. Oedematiens), Equine
65/093 Anti-Thyroglobulin Serum, Human (WHO Reference reagent)
65/119 Renin, Porcine
65/122 Long-acting Thyroid Stimulator, Human
66/021 Tetanus Antitoxin, Equine, for Flocculation Test
66/138 Gastrin II, Porcine
66/153 Diphtheria Antitoxin, Equine
66/233 Anti-Nuclear Factor Serum (Homogenous) Human
67/037 Immunoglobulin D (IgD) Serum, Human
67/086 Immunoglobulins G, A, M Serum Human (International Standard)
67/099 Immunoglobulins G, A & M Serum Human
67/182 Anti-Rubella Serum, Human
67/183 Primary Biliary Cirrhosis Serum, Human
68/340 Anti-Nucleolar Factor Plasma, Human
68/356 Renin, Human (International Standard)
69/065 Autoimmune Antibody to Human Spermatazoa
69/194 Glucagon, Porcine (First International Standard)
70/302 Angiotensin II (25µg)
71/281 Anti-Malaria Plasma P Vivax
71/326 Anti-Malaria Plasma Vivax Ng2
72/092 Anti-malaria Plasma: Plasmodium falciparum (Ghana)
72/096 Anti-Malaria Serum (P.Malariae)
72/341 Anti-Malaria Plasma P Falciparum
72/345 Anti-Malaria Plasma P Falciparum
72/348 Anti-Malaria Plasma P Vivax
73/517 Anti-D (Rho) Antibodies, Human
73/545 Placental Lactogen, Human (International Reference Preparation)
73/554 Cholera Vaccine (Inaba)
73/556 Cholera Vaccine (Ogawa)
73/601 Carcinoembryonic Antigen (CEA), Human (1st International Reference Preparation)
74/520 Serum Proteins (Other than Immunoglobulins) Human
74/581 Ancrod (1st International Reference Preparation)
74/586 Corticotrophin (ACTH), Porcine (International Working Standard)
75/506 Cocksfoot Pollen Extract
75/533 Chorionic Gonadotrophin, Human, for Radioiodination
75/535 Chorionic Gonadotrophin beta, Human, for Radioiodination
75/551 Chorionic Gonadotrophin beta Subunit, Human (International Reference Preparation)
75/569 Chorionic Gonadotrophin alpha subunit, Human (International Reference Preparation)
75/595 Blood Coagulation Factor Xa, Bovine
76/508 Chorionic Gonadotrophin alpha Subunit, Human, for Radioiodination
76/515 Mannan (Candida Albicans) Purified
76/522 Opacity 5IRP WHO International Standard
76/525 Anti-Birch Pollen Serum, Human
76/547 Influenza anti A/Victoria/3/75 Serum(goat)
76/575 Oxytocin(4th International Standard)
77/503 Anti-Cocksfoot Serum, Human
77/512 Lysine Vasopressin(1st International Standard)
77/531 Influenza anti A/New Jersey/8/76(H1N1) Serum
77/568 Influenza anti B/Hong Kong/8/73 Serum
77/584 Anti-D Pteronyssinus Serum, Human
77/600 Mannan (Candida Albicans) Purified
77/616 Twelve Grass Pollen Extract
77/643 Secretin
77/662 Acarus Siro Extract
77/664 Glycyphagus destructor Extract
78/517 Tyrophagus Putrescentiae Extract
78/543 Kininogenase (Porcine, Pancreatic) (Formerly 1st International Standard)
78/545 Anti-Aspergillus fumigatus Serum, Human
78/554 Luteinizing Hormone, Pituitary, alpha subunit (International Standard)
78/556 Luteinizing Hormone, Pituitary, beta subunit (International standard)
78/560 Influenza Antigen A/Texas/1/77
78/569 Influenza anti A/Texas/1/77 Serum
78/575 Aspergillus Fumigatus Extract
78/582 Tyrophagus Longior Extract
78/628 Bee Venom
79/500 Parathyroid Hormone, HumanRef. Preparation)
79/516 Influenza anti A/Brazil/11/78 Serum (goat)
79/552 Influenza Antigen A/USSR/92/77
79/558 Influenza Antigen A/USSR/92/77
79/560 Influenza Antigen A/Brazil/11/78
79/568 Influenza Antigen B/Hong Kong/8/73
79/572 Prekallikrein Activator (PKA), Human
80/505 Growth Hormone, Human, Pituitary. WHO International Standard
80/517 Influenza Antigen A/Bangkok/1/79
80/519 Influenza Antigen B/Singapore/222/79
80/523 Influenza anti B/Singapore/222/79 Serum
80/525 Influenza anti A/Bangkok/1/79 Serum
80/590 Tetracosactide. International Ref. Preparation
81/535 Luteinizing Hormone, Human, Pituitary (3rd International Standard)
81/565 Thyroid Stimulating Hormone, Human. WHO International Standard
82/508 Parathyroid Hormone, Human-Type, Synthetic (1-34) fragment
82/512 Parathyroid Hormone, Bovine-Type, Synthetic (1-34) fragment
82/518 Dermatophagoides Pteronyssinus Extract. WHO International Standard
82/520 Timothy Pollen Extract. WHO International Standard
82/585 Anti Poliovirus serum types 1,2 and 3 (3rd International Standard)
82/587 Interferon Gamma (Human, Leukocyte derived)
82/632 Parathyroid Hormone, Bovine. WHO International Standard
82/652 Human Serum Vitamin B12, Pernicous anaemia
83/501 Beta Thromboglobulin, Purified Human. WHO International Standard
83/505 Platelet Factor 4 Human, Purified. WHO International Standard
83/511 Insulin, Bovine. WHO International Standard
83/514 Interferon alpha-1D, (Human rDNA derived) WHO International Standard
83/515 Insulin, Porcine. WHO International Standard
83/537 Influenza Antigen A/Philippines/2/82
83/545 Influenza anti A/Philippine/2/82 Serum
83/550 Influenza Antigen A/Brazil/11/78
83/573 Prolactin, Human (4th WHO International Standard.)
83/575 Follicle Stimulating Hormone, Pituitary. WHO International Standard
84/514 Proinsulin, Bovine. International Ref. Preparation
84/522 Birch Pollen Extract. WHO International Standard
84/528 Proinsulin, Porcine. International Ref. Reagent
84/538 Influenza Antigen A/Chile/1/83
84/542 Influenza Antigen B/Norway/1/84
84/581 Short Ragweed Pollen Extract. WHO International Standard
84/614 Calcitonin, ASU 1-7 Eel Calcitonin Analogue (Elcatonin) WHO International Standard
84/628 Anti-c Serum, Human
84/636 Influenza anti B/USSR/100/83 Serum
84/640 Influenza anti A/Chile/1/8 Serum
84/677 Influenza anti A/equine/Miami/63 (H3N8) Serum(goat)
84/685 Dog (Canis Familiaris) Hair Dander Extract. WHO International Standard
85/506 C-Reactive Protein, Human. WHO International Standard
85/516 Influenza anti A/Equine/Kentucky/1/81 HA Serum
85/520 Influenza Antigen A/Equine/Kentucky/1/81
85/522 Thyroid Stimulating Hormone beta subunit
85/551 Anti-Rye Grass Serum, Human
85/616 Haemoglobin F Lysate, Raised. WHO Reference Reagent
85/669 Atrial Natriuretic Factor, Human. WHO International Standard
86/500 Interleukin- 2 (Human, rDNA derived)(2nd International Standard)
86/536 Angiotensin I Human Type Synthetic
86/538 Angiotensin II (2.5µg)
86/552 Interleukin-1 Beta (Human, rDNA derived)
86/576 Influenza Antigen A/Mississippi/1/85
86/590 Influenza anti A/Mississippi/1/85 Serum
86/592 Influenza anti B/Ann Arbor/1/86/HA Serum
86/630 Influenza Antigen B/Ann Arbor/ 1/86
86/632 Interleukin-1 alpha (Human rDNA derived) WHO International Standard
86/678 Interleukin-1 alpha (Human, rDNA derived)
86/680 Interleukin-1 beta (Human, rDNA derived) WHO International Standard
86/690 Inhibin, Porcine WHO International Standard
87/510 Influenza Antigen A/Equine/Miami/63
87/578 Influenza anti A/Leningrad/360/86 Serum
87/584 Influenza Antigen A/Leningrad/360/86
87/586 Interferon Gamma (Human, rDNA derived)
87/640 Tumour Necrosis Factor beta (Human, rDNA derived) WHO Reference Reagent
87/654 Anti-Ferritin Monoclonal Antibody (1)
87/662 Anti-Ferritin Monoclonal Antibody (2)
87/714 Influenza Antigen A/Sichuan/2/87
87/774 Influenza Antigen B/Victoria/2/87
88/522 Bordetella pertussis (Whole cell vaccine) 3BRP
88/532 Tumour Necrosis Factor alpha (Mouse, rDNA derived)
88/554 Influenza Antigen B/Beijing/1/87
88/556 Calcitonin, Eel WHO International Standard
88/638 Thyroxine-binding globulin. WHO International Standard
88/646 Granulocyte Macrophage Colony Stimulating Factor (Human, rDNA derived) WHO International Standard
88/654 Influenza Antigen A/England/427/88
88/656 Interleukin-4 (Human, rDNA derived) WHO International Standard
88/672 Influenza anti A/Sichuan/2/87 Serum
88/678 Influenza anti B/Beijing/1/87 Serum
88/846 Influenza anti A/England/427/88 Serum
89/512 Macrophage Colony Stimulating Factor (CSF-1) (Human rDNA derived) WHO International Standard
89/514 Transforming Growth Factor beta-1 (Human, rDNA derived)
89/516 Transforming Growth Factor beta-1 (Bovine)
89/518 Transforming Growth Factor beta-2 (Bovine)
89/520 Interleukin-8 (Human, rDNA derived) WHO International Standard
89/530 Anti-Bordetella pertussis serum (Human)
89/544 Renin, Human, rec DNA
89/548 Interleukin-6 (Human, rDNA derived) WHO International Standard
89/568 Influenza Antigen A/OMS/5389/88
89/594 Bordetella pertussis (W28) LPS 2ug
89/596 Bordetella pertussis anti-agglutinogen 1(rabbit)
89/598 Bordetella pertussis anti-agglutinogen 2 (rabbit)
89/600 Bordetella pertussis anti-agglutinogen 3 (rabbit)
89/620 Calcitonin, Human. WHO International Standard
89/666 Haemoglobin A2 Lysate, Raised. WHO Reference Reagent
89/670 Bordetella pertussis (W28) LPS25ug
90/500 Influenza Antigen A/Shanghai/16/89
90/502 Influenza Antigen A/Guizhou/54/89
90/504 Influenza anti A/Guangdong/39/89 Serum
90/520 Bordetella pertussis, filamentous haemagglutinin (FHA)
90/530 Interleukin-7 (Human, rDNA derived) WHO Reference Reagent
90/534 Mumps Vaccine (Live) WHO Reference Reagent
90/586 Interleukin-5 (Human, rDNA derived) WHO Reference Reagent
90/636 HIV-1 P24 Antigen WHO International Standard
90/690 Anti-Varicella-Zoster Antibody
90/696 Transforming Growth Factor beta-2, Human, rec DNA
90/712 Basic Fibroblast Growth Factor (Human, rDNA derived) WHO International Standard
90/784 Influenza Virus infectious NIB-26 (H3N2)
91/510 Interleukin-3 (Human, rDNA derived) WHO International Standard
91/530 Epidermal Growth Factor (Human, rDNA derived) WHO International Standard
91/550 Epidermal Growth Factor (1-52) (Human, rDNA derived) WHO Reference Reagent
91/554 Insulin-like growth Factor 1 WHO International Standard
91/612 Influenza anti A/Taiwan/1/86 Serum
91/624 Recombinant Human Inhibin
91/626 Activin A, Human, Recombinant. WHO Reference Reagent
91/656 Interleukin-4 (Mouse, rDNA derived)
91/658 Granulocyte Macrophage Colony Stimulating Factor (Mouse rDNA derived)
91/662 Interleukin-3 (Mouse, rDNA derived)
91/670 Influenza Virus infectious NIB-27 (H1N1)
91/678 Interleukin-9 (Human,rDNA derived) WHO Reference Reagent
91/682 Stem Cell Factor (Human rDNA derived) WHO Reference Reagent
91/688 Rubella Vaccine (Live) 1st International Reference Reagent
92/510 Follicle Stimulating Hormone, Human, recombinant. (WHO International Standard)
92/512 Follicle Stimulating Hormone, urofollitropin Human Urinary WHO International Standard
92/518 Macrophage Inflammatory Protein-1 alpha (Human, rDNA derived)
92/520 Rantes (Human, rDNA derived)
92/530 Influenza Antigen A/Texas/36/91
92/582 Influenza anti B/Yamagata/16/88 Serum
92/628 Influenza Antigen B/Yamagata/16/88
92/632 Influenza anti A/Beijing/352/89 (H3N2) Serum
92/644 Interleukin-1 Receptor Antagonist (IL-1ra) (Human, rDNA derived)
92/648 Measles Vaccine (Live) 2nd International Reference Reagent
92/654 Plasminogen Activator Inhibitor-1 (PAI-1), plasma Human WHO International Standard
92/658 Papain preparation for use with Anti-D preparation 91/562
92/680 Serum amyloid A protein. WHO International Standard
92/734 Influenza Virus infectious A/Beijing/32/92 (H3N2)
92/738 Influenza Virus infectious A/Shanghai/24/90
92/788 Interleukin-11 (Human, rDNA derived) WHO Reference Reagent
92/794 Monocyte Chemoattractant Protein-1 (Human,rDNA derived)
93/500 Influenza Antigen A/Beijing/32/92
93/516 Influenza Antigen A/Shanghai/24/90
93/518 Influenza anti A/Beijing/32/92 (H3N2) Serum
93/522 Influenza anti A/Shanghai/24/90 (H3N2) Serum
93/556 Nerve Growth Factor (Human, rDNA derived) WHO Reference Reagent
93/560 Insulin-like growth Factor Binding Protein-3
93/562 Leukaemia Inhibitory Factor (Human, rDNA derived) WHO Reference Reagent
93/564 Oncostatin M (Human, rDNA derived) WHO Reference Reagent
93/566 Interleukin-2 (Mouse, rDNA derived)
93/568 Influenza Virus infectious A/Beijing/359/89 (H3N2)
93/574 Bone morphogenetic Protein-2 (Human, rDNA derived) WHO Reference Reagent
93/668 Interleukin-1 beta (Mouse, rDNA derived)
93/672 Interleukin-1 alpha (Mouse, rDNA derived)
93/692 Influenza Virus infectious B/Panama/45/90
93/722 Interleukin-10 (Human rDNA derived) WHO Reference Reagent
93/730 Interleukin-6 (Mouse, rDNA derived)
93/740 Interleukin-7 (Mouse, rDNA derived)
93/816 Influenza Virus infectious A/Harbin/15/92 (H3N2)
94/500 Influenza Antigen B/Panama/45/90
94/504 Influenza anti A/Shanghai/9/93 Serum
94/516 Influenza Antigen A/Shangdong/9/93
94/520 Influenza anti B/Panama/45/90 Serum
94/532 Pertussis Vaccine (Whole Cell) WHO International Standard
94/622 Interleukin-13 (Human, rDNA derived) WHO Reference Reagent
94/674 Thyroid Stimulating Hormone, Human recombinant WHO Reference Reagent
94/684 Ciliary Neurotrophic Factor (Human, rDNA derived) WHO Reference Reagent
94/718 Staphylokinase, rec (STAR)
94/728 Platelet-derived Growth Factor-BB (Human, rDNA derived) WHO International Standard
94/730 Tissue Plasminogen Activator (tPA) Antigen in Plasma WHO International Standard
94/754 Interferon Omega (Human, rDNA derived) WHO International Standard
94/762 Influenza Virus infectious RESVIR-8 (H3N2)
94/766 Influenza Virus infectious NIB-34 (H3N2)
94/784 Interferon alpha (Human, leukocyte derived)WHO International Standard
94/786 Interferon alpha Concensus Sequence (Human rDNA derived) WHO International Standard
94/790 MAPREC analysis of Poliovirus type 3 (Sabin). Synthetic DNA 100% 472-C WHO International Standard
95/510 Influenza Antigen A/Texas/36/91
95/516 Influenza Antigen A/Johannesburg/33/94
95/522 Anti-HBc (Anti-hepatitis B core antigen) WHO International Standard
95/524 Influenza anti A/Johannesburg/33/94 Serum
95/528 Folate, Whole Blood Haemolysate WHO International Standard
95/542 MAPREC analysis of Poliovirus type 3 (Sabin) Synthetic DNA 0.9% 472-C WHO International Standard
95/544 Interleukin-12 (Human, rDNA derived) WHO Reference Reagent
95/554 Interleukin-15 (Human, rDNA derived) WHO Reference Reagent
95/564 Single Chain Urinary-Type Plasminogen Activator (SCuPA), (Non-Glyc)
95/568 Interferon Alpha n1 (Human lymphoblastoid cell derived) WHO International Standard
95/572 Interferon alpha-1/8 (Human, rDNA derived) WHO International Standard
95/574 Interferon Alpha n3 (Human, leukocyte derived) WHO International Standard
95/580 Interferon alpha-2c (Human, rDNA derived) WHO International Standard
95/646 Parathyroid Hormone 1-84, human, recombinant (1st International Standard)
95/650 Interferon alpha-2a (Human, rDNA derived) WHO International Standard
95/656 Interferon alpha 2b (Human rDNA derived)(3rd International Standard)
95/668 Single Chain Urinary-Type Plasminogen Activator (SCuPA), (Glyc)
95/674 Anti-Meningococcal Serogroup A mAb
95/678 Anti-Meningococcal Serogroup C mAb
96/528 Soluble Tumour Necrosis Factor Receptor Type 1, (Human, rDNA derived)
96/532 FMS-like tyrosine kinase 3 ligand (Human, rDNA derived) WHO Reference Reagent
96/534 Brain-derived Neurotrophic Factor (Human, rDNA derived) WHO Reference Reagent
96/538 Insulin-like growth Factor-II (Human rDNA derived) WHO Reference Reagent
96/556 Hepatocyte Growth Factor/Scatter Factor (precursor), (Human rDNA derived) WHO International Standard
96/564 Hepatocyte Growth Factor/Scatter Factor (Human, rDNA derived) WHO Reference Reagent
96/572 MAPREC analysis of Poliovirus type 3 (Sabin) Low virus reference 0.7%472-C WHO Reference Reagent
96/578 MAPREC analysis of Poliovirus type 3 (Sabin) High virus reference 1.1%472-C WHO Reference Reagent
96/602 Luteinizing Hormone, Human, recombinant WHO International Standard
96/784 Inhibin B, Human WHO Reference Reagent
96/836 Influenza Virus infectious RESVIR-9 (H3N2)
96/850 Influenza Virus infectious NIB-39 (H1N1)
97/518 Influenza Antigen A/Johannesburg/82/96
97/538 Anti-Granulocyte Macrophage Colony Stimulating Factor Serum
97/550 Islet Cell Antibodies WHO Reference Reagent
97/558 Bordetella pertussis anti 69kD serum (sheep)
97/562 Blood Coagulation Factors IXa Concentrate, Human, recombinant(1st I.S.)
97/564 Bordetella pertussis anti FHA serum (sheep)
97/572 Bordetella pertussis PT anti serum (sheep)
97/574 Bordetella pertussis anti Fim3 serum (sheep)
97/584 Influenza Antigen A/Equine/Newmarket/2/93
97/594 Leptin, Human, Recombinant WHO International Standard
97/596 Influenza Antigen A/Equine/Newmarket/1/93
97/600 Interleukin-2 Soluble Receptor (human, rDNA derived)
97/610 Influenza anti A/equine/Newmarket/1/93 Serum
97/612 Influenza anti- A/Nanchang/933/95 (H3N2) HA serum
97/614 Influenza anti A/Equine/Newmarket/2/93 (H3N8) HA Serum (SH-376)
97/626 Leptin, Mouse, Recombinant WHO International Standard
97/642 Bordetella pertussis anti serum (mouse) 1RR
97/646 Anti-Hepatitis A Immunoglobulin, Human (W1041) WHO International Standard
97/648 Anti-Measles serum (3rd International Standard)
97/692 Influenza Virus infectious IVR-108 (H3N2)
97/714 Prolactin, Human, recombinant. WHO Reference Reagent
97/722 Influenza Virus infectious A/duck/Sing-Q/119/97 (H5N3)
97/748 Influenza Antigen B/Harbin/7/94
97/756 MAPREC analysis of Poliovirus type 2 (Sabin), low virus reference 0.65%481-G. WHO Reference Reagent
97/758 MAPREC analysis of Poliovirus type 2 (Sabin) Synthetic DNA 0.67%481-G WHO International Standard
97/760 Influenza Antigen A/Beijing/262/95
98/524 MAPREC analysis of Poliovirus type 2 (Sabin) Synthetic DNA, 100%481-G WHO International Standard
98/544 Influenza Virus infectious RESVIR-13 (H3N2)
98/572 Diphtheria and Tetanus Antitoxin, Guinea Pig Serum
98/574 Somatropin WHO International Standard
98/580 Prolactin Human, recombinant, glycosylated WHO Reference Reagent
98/582 Prolactin, Human, recombinant, non-glycosylated WHO Reference Reagent
98/586 Calcitonin, Salmon. WHO International Standard
98/596 MAPREC analysis of Poliovirus type 2 (Sabin), high virus reference 1.21% 481-G. WHO Reference Reagent
98/600 Influenza Virus infectious NIB-40 (H5N3)
98/604 Influenza anti B/Harbin/7/94/HA Serum
98/610 Influenza Virus infectious ARIV-1 (H5N3)
98/666 Influenza anti A/Hong Kong/489/97 (H5N1) Serum (sheep)
98/686 Negative Control Guinea Pig Serum (Diphtheria and Tetanus Serology)
98/708 Haemiglobincyanide WHO International Standard
98/714 Tissue Plasminogen Activator, Human, Recombinant WHO International Standard
98/718 Neurotrophin 3
98/762 Influenza Virus infectious Resvir-14 (H3N2)
98/772 Influenza anti A/Beijing/262/95 Serum
98/774 Influenza Antigen B/Shangdong/7/97
98/778 Influenza Virus infectious A/Sichuan/346/98 (H3N2)
99/506 Anti-PT S1 subunit Monoclonal Antibody (1B7)
99/508 Anti-PT S1 subunit Monoclonal Antibody (1D7)
99/510 Anti-PT S1 subunit Monoclonal Antibody (3F11)
99/512 Anti-PT S1 subunit Monoclonal Antibody (10D6)
99/514 Anti-PT S1 subunit Monoclonal Antibody (8G4)
99/516 Anti-PT S1 subunit Monoclonal Antibody (E1E)
99/518 Anti-PT S1 subunit Monoclonal Antibody (E2E)
99/520 Anti-PT S1 subunit Monoclonal Antibody (3F10)
99/522 Anti-PT S1 subunit Monoclonal Antibody (11D9)
99/524 Anti-PT S1 subunit Monoclonal Antibody (4D10)
99/526 Anti-PT S23 subunit Monoclonal Antibody (11E6)
99/528 Anti-PT S23 subunit Monoclonal Antibody (10C9)
99/530 Anti-PT S23 subunit Monoclonal Antibody (10B5)
99/532 Anti-PT S23 subunit Monoclonal Antibody (G9A)
99/534 Anti-PT S23 subunit Monoclonal Antibody (3F6)
99/536 Anti-PT S2 subunit Monoclonal Antibody (3A12)
99/538 Anti-PT S2 subunit Monoclonal Antibody (2H3)
99/540 Anti-PT S2 subunit Monoclonal Antibody (9G8)
99/542 Anti-PT S3 subunit Monoclonal Antibody (7E10)
99/544 Anti-PT S3 subunit Monoclonal Antibody (7G11)
99/546 Anti-PT S3 subunit Monoclonal Antibody (4G5)
99/548 Anti-PT S3 subunit Monoclonal Antibody (2E12)
99/550 Anti-PT S3 subunit Monoclonal Antibody (6F8)
99/552 Anti-PT S3 subunit Monoclonal Antibody (10B8)
99/554 Anti-PT S4 subunit Monoclonal Antibody (7F2)
99/556 Anti-PT S4 subunit Monoclonal Antibody (6B3)
99/558 Anti-PT S4 subunit Monoclonal Antibody (6G8)
99/560 Anti-PT S4 subunit Monoclonal Antibody (9F3)
99/562 Anti-PT S4 subunit Monoclonal Antibody (1H2)
99/564 Anti-PT S4 subunit Monoclonal Antibody (9C6)
99/566 Anti-PT S4 subunit Monoclonal Antibody (6D6)
99/568 Anti-PT S5 subunit Monoclonal Antibody (7E3)
99/570 Anti Filamentous Haemagglutinin Monoclonal Antibody (1C6)
99/572 Anti-Filamentous Haemagglutinin Monoclonal Antibody (2E9)
99/574 Anti Filamentous Haemagglutinin Monoclonal Antibody (12G10)
99/586 Influenza Antigen B/Yamanashi/166/98
99/614 Influenza Antigen A/Sydney/5/97
99/616 Yellow Fever Vaccine. WHO International Standard
99/624 Influenza Antigen A/Sydney/5/97
99/642 Chorionic Gonadotrophin, nicked, human. WHO Reference Reagent
99/650 Chorionic Gonadotrophin, beta subunit, human. WHO Reference Reagent
99/666 Anti-HPA-5b (Minimum Potency) WHO Reference Reagent
99/674 HIV-2 (antibody) Monitor Sample
99/688 Chorionic Gonadatrophin, intact, Human. WHO Reference Reagent
99/692 Chorionic Gonadotrophin, nicked beta subunit, Human WHO Reference Reagent
99/706 Anti-Meningococcal human reference serum CDC1992
99/708 Chorionic Gonadatrophin, beta core fragment, Human WHO Reference Reagent
99/710 Anti-HIV 1 (1 in 5 BWS)
99/714 Influenza Antigen A/Singapore/1/57 (H2N2)
99/720 Chorionic Gonadotrophin, alpha subunit, Human (purified)
99/750 British Working Standard for Anti-HIV 1
99/824 Influenza Virus infectious RESVIR 16 (H3N2)
99/828 Influenza Antigen B/Yamanashi/166/98
99/836 Anti-D Minimum Potency Standard for blood grouping reagents WHO International Standard
AFP Alpha-Foetoprotein. WHO International Standard
BUSB Botulinum Antitoxin Equine Type B. WHO International Standard
CDS Anti-Canine Distemper Serum. WHO International Standard
CHAN Cholera Antitoxin, Goat. WHO International Standard
CHS Anti-Canine Hepatitis Serum
COT Clostridium novyi (alpha) Toxoid. WHO Reference Reagent
CWBETATD Clostridium Welchii (Perfringens)(Beta) Toxoid CwBT WHO Reference Reagent
CWEPSILTD Clostridium Welchii (Perfringens) (Epsilon) toxoid
DY Anti-Dysentery (shiga) serum, Equine. WHO International Standard
HBOHA Lyophilised HBO-HA Antigen for ELISA, Lot 17
JNIH-11 Bordetella pertussis anti FHA serum (mouse)
JNIH-12 Bordetella pertussis PT( LPF) anti serum, (mouse)
JNIH-3 Acellular Pertussis Vaccine - 1st IS.
JNIH-4 Bordetella pertussis filamentous haemagglutinin (FHA)
MEF/001 Primary Mouse Embryo Fibroblasts (p0)
MGDS Anti-Mycoplasma gallisepticum Serum. WHO Reference Reagent
NDS Anti-Newcastle Disease Serum. WHO International Standard
NVIA Newcastle Disease Vaccine (Inactivated) WHO International Standard
OE Gas Gangrene Antitoxin (Cl. novyi), Equine WHO International Standard
PE Gas Gangrene Antitoxin (Cl. Perfringens alpha antitoxin) Equine WHO International Standard
PPDA Purified Protein Derivative (PPD) of M Avium Tuberculin WHO International Standard
PPDBOV Purified Protein Derivative (PPD) of Mycobacterium bovis Tuberculin (WHO 1st International Standard)
PPDT Purified Protein Derivative (PPD) of M. Tuberculosis Tuberculin WHO International Standard
QF Anti-Q Fever Serum, Bovine WHO International Standard
RBT/16 Thromboplastin, Rabbit, Plain 5th International Standard 2016.
RTF/16 Thromboplastin, Human, Recombinant, Plain 5th International Standard 2016.
RUBI-1-94 Anti-rubella Immunoglobulin, Human WHO International Standard
SES Swine Erysipelas Serum (anti-N) WHO Reference Reagent
SFS Anti-Swine Fever Serum WHO International Standard
SMV Smallpox Vaccine WHO International Standard
SPDS-S2 Anti-Salmonella Pullorum Serum (Std. Form S) WHO International Standard
SPDS-V Anti-Salmonella Pullorum Serum (Variant Form V) WHO International Standard
SPLS Anti-Staphylococcal P-V Leucocidin serum, Equine WHO Reference Reagent
SS-319/20 FITC CD4 Positive Control Cells
SSCLOT5 SSC Secondary Coagulation Standard Lot#5
STA Staphylococcus Alpha Antitoxin, Equine WHO International Standard
STT Diphtheria (Schick) Test Toxin WHO International Standard
TILI Anti-tick borne encephalitis serum (Louping Ill) WHO International Standard
TISA Anti-tick borne encephalitis serum (Sophyn & Absettarov) WHO International Standard
TYVK Typhoid Vaccine (acetone-inactivated) WHO International Standard
TYVL Typhoid Vaccine (heat-phenol-inactivated) WHO International Standard
VI Gas Gangrene Antitoxin (Cl. Septicum), Equine WHO International Standard
W1004 Anti-C complete blood typing serum,human WHO International Standard
W1005 Anti-E complete blood typing serum, human WHO International Standard
W1007 Anti-c Incomplete blood typing serum, human WHO International Standard
W1044 Anti-Varicella zoster immunoglobulin WHO International Standard
W1062 Anti smooth muscle(anti actin) autoantibody. WHO Reference Reagent
W1063 Anti nuclear ribonucleoprotein(nRNP) autoantibody WHO Reference Reagent
W1064 Anti-Nuclear factor serum,homogenous(66/233)
YF Anti-Yellow Fever Serum, monkey WHO Reference Reagent